Real time continuous glucose monitoring in high-risk people with insulin-requiring type 2 diabetes: A randomised controlled trial.

Claire S LeverJonathan A WillimanAlisa BoucseinAntony WatsonRachael S SampsonOscar T Sergel-StringerCeleste KeesingLynne ChepulisBenjamin J WheelerMartin I de BockRyan G Paul

Published in: Diabetic medicine : a journal of the British Diabetic Association (2024)

Real-time CGM use in a supportive treat-to-target model of care likely improves glycaemia in a population with insulin-treated T2D and elevated HbA1c.

Keyphrases

type diabetes
glycemic control
healthcare
palliative care
cardiovascular disease
weight loss
metabolic syndrome
chronic pain
affordable care act